Jonathan McNeill, See Remarks at Dyne Therapeutics, Inc. (DYN), sold 2,209 shares at $13.00 ($29K) on 2023-03-13, disclosed to the SEC on 2023-03-15.
Scheduled sale ($29k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.00 | 1,000 | $13K | 44.6% |
| 2 | $13.33 | 1,209 | $16K | 55.4% |
| Total | $13.18 avg | 2,209 | $29K | 100% |
| Filing → |
| DYN | SELL | 2024-08-20 | $122K | — | Filing → |
| DYN | SELL | 2024-06-11 | $114K | — | Filing → |
| DYN | SELL | 2024-05-17 | $143K | — | Filing → |